Michael J. Weil

 

Michael J. Weil

Associate | 312-364-2500 | mweil@lowis-gellen.com

Mr. Weil concentrates his practice in intellectual property law with an emphasis on patent law, representing inventors and businesses in patent prosecution, IP transactional work and litigation. Prior to joining Lowis & Gellen LLP, Mr. Weil worked with a Chicago-based patent law firm.

Professional Activities

Mr. Weil is a licensed patent attorney. He was admitted to the Illinois Bar in 2015 and became registered to practice by the United States Patent and Trademark Office in 2016. He is an active member in the American Bar Association, the Illinois State Bar Association, and the Chicago Bar Association. He is also a member of the Decalogue Society of Lawyers, where he has lectured.

Education

Mr. Weil received his J.D. from Fordham University School of Law, where he was awarded the Archibald R. Murray Award for Public Service. While at Fordham, Mr. Weil served as a mediator in New York City’s civil court, and edited Fordham’s Intellectual Property Law Journal. As an undergraduate, Mr. Weil received a B.A. in History cum laude from Brandeis University and also studied biology, chemistry, and physics.

Publications

Michael J. Weil, “Hold the Mayo: Vanda ruling reviews patent subject matter eligibility”, Illinois State Bar Association, Intellectual Property Law Newsletter, Volume 57, No. 4 (June 2018)

Michael J. Weil, “Stop the music? Spotify sued for $1.6 billion”, Illinois State Bar Association, Intellectual Property Law Newsletter, Volume 57, No. 3 (March 2018)

Michael J. Weil and Andrew C. Warnecke, “Helsinn v. Teva: The America Invents Act on ‘sale’,” Illinois State Bar Association, Intellectual Property Law Newsletter, Volume 57, No. 2 (November 2017)

Michael J. Weil and Steven L. Baron, “Sandoz v. Amgen: The Supreme Court makes its first decision on biosimilars,” Illinois State Bar Association, Intellectual Property Law Newsletter, Volume 57, No. 1 (September 2017)

Steven L. Baron and Michael J. Weil, “Sandoz v. Amgen: Biosimilars arrive at the Supreme Court,” Illinois State Bar Association, Intellectual Property Law Newsletter, Volume 56, No. 5 (June 2017)



Back to Our Attorneys >